Business | Thomson Reuters | Thursday March 17, 2016
GlaxoSmithKline said on Thursday its Chief Executive Andrew Witty would retire in 12 months time, after leading the group since 2008, prompting Britain's biggest drugmaker to start a formal search for his successor.
www.ndtv.com/business